Greetings. Welcome to the Cellectis Q3 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator ...

PARIS--(BUSINESS WIRE)--At yesterday's Annual General Meeting, the members of France Biotech (the French association for life science entrepreneurs: www.france-biotech.org) voted to elect their ...

Gene-editing grabbed headlines recently after the discovery of CRISPR, a tool that allows scientists to cut out a particular, potentially faulty gene and paste another one in its place. Dozens of ...

SAN FRANCISCO—The future of CAR-T is off the shelf, according to Cellectis CEO André Choulika. Allogeneic CAR-T therapy, which uses donor T cells, has the potential to clear the hurdles that come with ...

Cellectis, which has built a clinical-phase pipeline consisting entirely of treatments that apply its proprietary TALEN ® gene editing technology, says the U.S. patent issued to the company this month ...

Dr. Yves Ribeill, Member of Calyxt’s Board of Directors since 2018, Appointed Chairman of the Board; Laurent Arthaud named Director, designated by Cellectis As part of its commitment to a cure, ...

Cellectis Says It Can Cut and Paste DNA Sequences with Its “Molecular Scissors” When a meganuclease enters a cell, it can cut out a mutation, repair the cell, and re-edit the genome for the spelling ...

CHICAGO--André Choulika does not mince words. The Cellectis CEO is an outspoken champion of all things related to the company he founded 15 years ago. Beirut-born, with a Ph.D. from the University of ...

Forget about cash—start banking your body. Using a technology that echoes science fiction movies, a French company is offering people a "bank" to store their own stem cells for years in a bet that ...

French biotech entrepreneur Andre Choulika is working on an unusual and pricey project: A stem cell bank for adults. Choulika’s stem cell bank, Sceil, is a new Singapore-based operation that claims to ...

Good morning, everyone. And welcome to the Cellectis Fourth Quarter 2021 and Year-End Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...